miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-155-5p | ||||
miRNA Stemloop AC | MI0000681 | ||||
miRNA Stemloop ID | hsa-mir-155 | ||||
Sequence | uuaaugcuaaucgugauaggggu | ||||
miRNA General Information | |||||
miRNA Mature ID | hsa-miR-155-5p | ||||
miRNA Stemloop AC | MI0000681 | ||||
miRNA Stemloop ID | hsa-mir-155 | ||||
Sequence | uuaaugcuaaucgugauagggguu | ||||
TTD Target(s) Regulated by This miRNA | Angiotensin II receptor type-1 (AGTR1) | Successful Target | Target Info | [1] | |
Interleukin-8 (IL8) | Successful Target | Target Info | [2] | ||
Intercellular adhesion molecule ICAM-1 (ICAM1) | Successful Target | Target Info | [3] | ||
Interleukin-2 (IL2) | Successful Target | Target Info | [4] | ||
Thyroid hormone receptor beta (THRB) | Successful Target | Target Info | [5] | ||
Vascular endothelial growth factor receptor 1 (FLT-1) | Successful Target | Target Info | [6] | ||
Nitric-oxide synthase endothelial (NOS3) | Clinical trial Target | Target Info | [7] | ||
Stress-activated protein kinase 2a (p38 alpha) | Clinical trial Target | Target Info | [8] | ||
Wee1-like protein kinase (WEE1) | Clinical trial Target | Target Info | [9] | ||
Caspase-3 (CASP3) | Clinical trial Target | Target Info | [10] | ||
SH2 domain inositol 5'-phosphatase 1 (INPP5D) | Clinical trial Target | Target Info | [11] | ||
E-selectin (SELE) | Clinical trial Target | Target Info | [3] | ||
G1/S-specific cyclin-D1 (CCND1) | Clinical trial Target | Target Info | [12] | ||
Myosin light kinase (MYLK) | Clinical trial Target | Target Info | [9] | ||
T-cell-specific kinase (ITK) | Clinical trial Target | Target Info | [4] | ||
DNA-binding factor KBF1 (p105) | Clinical trial Target | Target Info | [2] | ||
Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Target Info | [13] | ||
Keratinocyte growth factor (FGF7) | Clinical trial Target | Target Info | [14] | ||
Colony stimulating factor-1 receptor (CSF-1R) | Clinical trial Target | Target Info | [9] | ||
Signal transducer and activator of transcription 1 (STAT1) | Patented-recorded Target | Target Info | [15] | ||
Myeloid differentiation primary response protein MyD88 (MYD88) | Literature-reported Target | Target Info | [16] | ||
Transcription regulator protein BACH1 (Bach1) | Clinical trial Target | Target Info | [17] | ||
von Hippel-Lindau disease tumor suppressor (VHL) | Patented-recorded Target | Target Info | [18] | ||
Transcription factor AP-1 (JUN) | Discontinued Target | Target Info | [19] | ||
Transforming protein RhoA (RHOA) | Discontinued Target | Target Info | [20] | ||
Lectin-like oxidized LDL receptor (OLR1) | Clinical trial Target | Target Info | [2] | ||
RNA-binding protein Musashi-2 (MSI2) | Discontinued Target | Target Info | [14] | ||
Mixed lineage kinase 2 (MAP3K10) | Literature-reported Target | Target Info | [9] | ||
cAMP-dependent protein kinase A type I (PRKAR1A) | Literature-reported Target | Target Info | [9] | ||
Oxysterols receptor LXR-alpha (NR1H3) | Patented-recorded Target | Target Info | [21] | ||
Phosphatase and tensin homolog (PTEN) | Literature-reported Target | Target Info | [22] | ||
Proto-oncogene c-Myc (MYC) | Literature-reported Target | Target Info | [23] | ||
Ras-related C3 botulinum toxin substrate 1 (RAC1) | Literature-reported Target | Target Info | [9] | ||
Casein kinase I alpha (CSNK1A1) | Clinical trial Target | Target Info | [14] | ||
Matrix metalloproteinase-16 (MMP-16) | Literature-reported Target | Target Info | [24] | ||
Mitotic growth and transcription activator (BAF190A) | Literature-reported Target | Target Info | [9] | ||
PAK-2 protein kinase (PAK2) | Literature-reported Target | Target Info | [9] | ||
Protein kinase N2 (PKN2) | Literature-reported Target | Target Info | [14] | ||
Serine/threonine-protein kinase NIK (MAP3K14) | Literature-reported Target | Target Info | [9] | ||
Annexin A2 (ANXA2) | Literature-reported Target | Target Info | [14] | ||
CCAAT/enhancer binding protein beta (CEBPB) | Literature-reported Target | Target Info | [25] | ||
DNA repair protein RAD51 homolog 1 (RAD51) | Clinical trial Target | Target Info | [26] | ||
Endothelin-1 (EDN1) | Literature-reported Target | Target Info | [27] | ||
Histidine ammonia-lyase (HAL) | Literature-reported Target | Target Info | [9] | ||
Interleukin 13 receptor alpha-1 (IL13RA1) | Literature-reported Target | Target Info | [28] | ||
Lysine-specific demethylase 3A (KDM3A) | Literature-reported Target | Target Info | [29] | ||
Protein C-ets-1 (ETS1) | Literature-reported Target | Target Info | [30] | ||
Proto-oncogene c-Fos (c-Fos) | Literature-reported Target | Target Info | [8] | ||
Vascular cell adhesion protein 1 (VCAM1) | Literature-reported Target | Target Info | [6] | ||
Acetyl-CoA transporter (SLC33A1) | Patented-recorded Target | Target Info | [9] | ||
Cysteine-rich angiogenic inducer 61 (CYR61) | Literature-reported Target | Target Info | [31] | ||
DNA mismatch repair protein Mlh1 (MLH1) | Literature-reported Target | Target Info | [32] | ||
DNA mismatch repair protein MSH2 (MSH2) | Literature-reported Target | Target Info | [32] | ||
F-box and WD-40 domain protein 7 (Fbxw7) | Literature-reported Target | Target Info | [33] | ||
Homeobox protein Nkx-3.1 (NKX3-1) | Literature-reported Target | Target Info | [9] | ||
Methyl cpg binding protein 2 (MECP2) | Clinical trial Target | Target Info | [34] | ||
Pleiotrophin (PTN) | Literature-reported Target | Target Info | [35] | ||
Polybromo-1 (PBRM1) | Literature-reported Target | Target Info | [14] | ||
Telomeric repeat-binding factor 1 (TERF1) | Literature-reported Target | Target Info | [36] | ||
Transcription factor E2F2 (E2F2) | Literature-reported Target | Target Info | [37] | ||
Runt-related transcription factor 2 (RUNX2) | Literature-reported Target | Target Info | [38] | ||
SSX2-interacting protein (SSX2IP) | Literature-reported Target | Target Info | [9] | ||
Suppressor of cytokine signaling 1 (SOCS1) | Literature-reported Target | Target Info | [39] | ||
Suppressor of cytokine signaling 3 (SOCS3) | Literature-reported Target | Target Info | [40] | ||
Inhibitor of nuclear factor kappa-B kinase (IKK) | Patented-recorded Target | Target Info | [41] | ||
Mothers against decapentaplegic homolog 3 (SMAD3) | Preclinical Target | Target Info | [42] | ||
Protein(s) Regulated by This miRNA | 14-3-3 protein zeta/delta | Regulated Protein | [9] | ||
28S ribosomal protein S27, mitochondrial | Regulated Protein | [9] | |||
39S ribosomal protein L18, mitochondrial | Regulated Protein | [9] | |||
Actin-related protein 2 | Regulated Protein | [9] | |||
Actin-related protein 2/3 complex subunit 3 | Regulated Protein | [9] | |||
Adenomatous polyposis coli protein | Regulated Protein | [44] | |||
ADP-ribosylation factor-like protein 15 | Regulated Protein | [9] | |||
Anamorsin | Regulated Protein | [9] | |||
Anaphase-promoting complex subunit 16 | Regulated Protein | [9] | |||
Apoptotic protease-activating factor 1 | Regulated Protein | [9] | |||
Arfaptin-1 | Regulated Protein | [9] | |||
Armadillo repeat-containing protein 2 | Regulated Protein | [9] | |||
Asparagine--tRNA ligase, cytoplasmic | Regulated Protein | [9] | |||
Astrocytic phosphoprotein PEA-15 | Regulated Protein | [35] | |||
AT-rich interactive domain-containing protein 2 | Regulated Protein | [25] | |||
B-cell lymphoma 6 protein | Regulated Protein | [47] | |||
Calcium-binding protein 39 | Regulated Protein | [9] | |||
Calcium-regulated heat-stable protein 1 | Regulated Protein | [9] | |||
cAMP-dependent protein kinase inhibitor alpha | Regulated Protein | [48] | |||
Carbonyl reductase family member 4 | Regulated Protein | [9] | |||
Caspase recruitment domain-containing protein 11 | Regulated Protein | [9] | |||
Centrosomal protein of 41 kDa | Regulated Protein | [9] | |||
Centrosomal protein of 83 kDa | Regulated Protein | [9] | |||
Chromodomain-helicase-DNA-binding protein 9 | Regulated Protein | [9] | |||
Claudin-1 | Regulated Protein | [49] | |||
Clusterin-associated protein 1 | Regulated Protein | [9] | |||
Coiled-coil domain-containing protein 82 | Regulated Protein | [9] | |||
Cytochrome b-c1 complex subunit Rieske, mitochondrial | Regulated Protein | [50] | |||
Cytochrome P450 2U1 | Regulated Protein | [9] | |||
Cytoskeleton-associated protein 5 | Regulated Protein | [51] | |||
DCN1-like protein 2 | Regulated Protein | [9] | |||
Dedicator of cytokinesis protein 1 | Regulated Protein | [49] | |||
Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | Regulated Protein | [52] | |||
DET1 homolog | Regulated Protein | [25] | |||
DNA helicase MCM8 | Regulated Protein | [9] | |||
DNA mismatch repair protein Msh6 | Regulated Protein | [32] | |||
DNA polymerase epsilon subunit 3 | Regulated Protein | [9] | |||
E3 ubiquitin-protein ligase RNF123 | Regulated Protein | [54] | |||
E3 ubiquitin-protein ligase TRIM32 | Regulated Protein | [55] | |||
Ethanolamine kinase 2 | Regulated Protein | [35] | |||
Exosome complex component RRP4 | Regulated Protein | [9] | |||
FAS-associated death domain protein | Regulated Protein | [56] | |||
Forkhead box protein O3 | Regulated Protein | [57] | |||
Friend leukemia integration 1 transcription factor | Regulated Protein | [30] | |||
G1/S-specific cyclin-D2 | Regulated Protein | [59] | |||
Gamma-aminobutyric acid receptor-associated protein-like 1 | Regulated Protein | [9] | |||
GC-rich sequence DNA-binding factor 2 | Regulated Protein | [9] | |||
Germinal center-associated signaling and motility protein | Regulated Protein | [60] | |||
Glycine amidinotransferase, mitochondrial | Regulated Protein | [9] | |||
Glycine amidinotransferase, mitochondrial | Regulated Protein | [14] | |||
GTP-binding protein Rheb | Regulated Protein | [9] | |||
Histone deacetylase complex subunit SAP30L | Regulated Protein | [9] | |||
Histone-lysine N-methyltransferase NSD3 | Regulated Protein | [2] | |||
HMG box-containing protein 1 | Regulated Protein | [9] | |||
Homeobox and leucine zipper protein Homez | Regulated Protein | [63] | |||
Homeobox protein cut-like 1 | Regulated Protein | [64] | |||
Homeobox protein Meis1 | Regulated Protein | [30] | |||
Immunoglobulin J chain | Regulated Protein | [9] | |||
InaD-like protein | Regulated Protein | [65] | |||
Integrator complex subunit 6 | Regulated Protein | [9] | |||
Interferon gamma receptor 1 | Regulated Protein | [66] | |||
Interleukin-17 receptor B | Regulated Protein | [9] | |||
Kelch repeat and BTB domain-containing protein 2 | Regulated Protein | [9] | |||
Kelch-like protein 5 | Regulated Protein | [9] | |||
Leucine-rich repeat-containing protein 59 | Regulated Protein | [9] | |||
Ligand of Numb protein X 2 | Regulated Protein | [9] | |||
Ligand-dependent nuclear receptor corepressor-like protein | Regulated Protein | [9] | |||
Ligand-dependent nuclear receptor-interacting factor 1 | Regulated Protein | [9] | |||
Lysine-rich coiled-coil protein 1 | Regulated Protein | [9] | |||
Macrosialin | Regulated Protein | [2] | |||
MAGUK p55 subfamily member 5 | Regulated Protein | [9] | |||
Matrin-3 | Regulated Protein | [17] | |||
Max-interacting protein 1 | Regulated Protein | [68] | |||
Meiosis regulator and mRNA stability factor 1 | Regulated Protein | [9] | |||
Microphthalmia-associated transcription factor | Regulated Protein | [69] | |||
Mitochondrial import inner membrane translocase subunit TIM14 | Regulated Protein | [9] | |||
Mitochondrial import receptor subunit TOM20 homolog | Regulated Protein | [9] | |||
Mitogen-activated protein kinase 13 | Regulated Protein | [70] | |||
MORC family CW-type zinc finger protein 3 | Regulated Protein | [9] | |||
Mothers against decapentaplegic homolog 2 | Regulated Protein | [42] | |||
Mothers against decapentaplegic homolog 4 | Regulated Protein | [42] | |||
Mothers against decapentaplegic homolog 5 | Regulated Protein | [25] | |||
Muscleblind-like protein 3 | Regulated Protein | [9] | |||
Myb-related protein A | Regulated Protein | [9] | |||
Myocyte-specific enhancer factor 2A | Regulated Protein | [9] | |||
Neuronal membrane glycoprotein M6-b | Regulated Protein | [72] | |||
NFATC2-interacting protein | Regulated Protein | [17] | |||
Pachytene checkpoint protein 2 homolog | Regulated Protein | [9] | |||
Paladin | Regulated Protein | [9] | |||
PC4 and SFRS1-interacting protein | Regulated Protein | [73] | |||
PDZ and LIM domain protein 5 | Regulated Protein | [9] | |||
Periplakin | Regulated Protein | [35] | |||
PHD finger protein 14 | Regulated Protein | [9] | |||
Phosphatidylinositide phosphatase SAC2 | Regulated Protein | [9] | |||
Phosphatidylinositol 3-kinase regulatory subunit alpha | Regulated Protein | [74] | |||
Phosphatidylinositol-binding clathrin assembly protein | Regulated Protein | [9] | |||
Plastin-1 | Regulated Protein | [9] | |||
Polyhomeotic-like protein 2 | Regulated Protein | [9] | |||
PRA1 family protein 3 | Regulated Protein | [9] | |||
Pre-mRNA-processing factor 17 | Regulated Protein | [9] | |||
Probable ATP-dependent RNA helicase DHX40 | Regulated Protein | [9] | |||
Probable E3 ubiquitin-protein ligase HERC4 | Regulated Protein | [9] | |||
Protein argonaute-4 | Regulated Protein | [9] | |||
Protein FAM135A | Regulated Protein | [30] | |||
Protein FAM177A1 | Regulated Protein | [9] | |||
Protein FAM199X | Regulated Protein | [9] | |||
Protein FAM91A1 | Regulated Protein | [9] | |||
Protein Jade-1 | Regulated Protein | [17] | |||
Protein Jumonji | Regulated Protein | [37] | |||
Protein KIBRA | Regulated Protein | [9] | |||
Protein LDOC1 | Regulated Protein | [17] | |||
Protein lin-7 homolog C | Regulated Protein | [9] | |||
Protein sel-1 homolog 1 | Regulated Protein | [76] | |||
Protocadherin-9 | Regulated Protein | [9] | |||
Rab11 family-interacting protein 2 | Regulated Protein | [9] | |||
Rap guanine nucleotide exchange factor 2 | Regulated Protein | [9] | |||
RB-associated KRAB zinc finger protein | Regulated Protein | [9] | |||
Regulator of nonsense transcripts 2 | Regulated Protein | [9] | |||
Regulatory-associated protein of mTOR | Regulated Protein | [77] | |||
RNA-binding protein Nova-1 | Regulated Protein | [9] | |||
Selenocysteine insertion sequence-binding protein 2 | Regulated Protein | [9] | |||
Serine/threonine-protein kinase greatwall | Regulated Protein | [14] | |||
Serine/threonine-protein kinase WNK1 | Regulated Protein | [35] | |||
SH3 and multiple ankyrin repeat domains protein 2 | Regulated Protein | [78] | |||
SH3 and PX domain-containing protein 2A | Regulated Protein | [78] | |||
Ski oncogene | Regulated Protein | [79] | |||
Solute carrier family 35 member F2 | Regulated Protein | [9] | |||
Suppressor of cytokine signaling 6 | Regulated Protein | [22] | |||
Suppressor of cytokine signaling 6 | Regulated Protein | [81] | |||
Syntenin-1 | Regulated Protein | [9] | |||
TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L | Regulated Protein | [9] | |||
TBC1 domain family member 14 | Regulated Protein | [9] | |||
TBC1 domain family member 8B | Regulated Protein | [9] | |||
Teashirt homolog 3 | Regulated Protein | [82] | |||
Tetraspanin-14 | Regulated Protein | [9] | |||
TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 | Regulated Protein | [64] | |||
Trafficking kinesin-binding protein 1 | Regulated Protein | [9] | |||
Transcription factor 12 | Regulated Protein | [9] | |||
Transcription factor A, mitochondrial | Regulated Protein | [83] | |||
Transcription factor HIVEP2 | Regulated Protein | [25] | |||
Transcription factor MafB | Regulated Protein | [78] | |||
Transcription factor PU.1 | Regulated Protein | [84] | |||
Transcription factor SOX-6 | Regulated Protein | [85] | |||
Transcription termination factor 1 | Regulated Protein | [9] | |||
Transducin-like enhancer protein 4 | Regulated Protein | [9] | |||
Transforming growth factor beta regulator 1 | Regulated Protein | [63] | |||
Transmembrane 6 superfamily member 1 | Regulated Protein | [17] | |||
Tubulin-specific chaperone A | Regulated Protein | [9] | |||
Tumor protein p53-inducible nuclear protein 1 | Regulated Protein | [86] | |||
Twinfilin-1 | Regulated Protein | [35] | |||
Ubiquilin-1 | Regulated Protein | [9] | |||
Ubiquitin domain-containing protein 2 | Regulated Protein | [9] | |||
Uncharacterized protein C17orf80 | Regulated Protein | [9] | |||
Uncharacterized protein C3orf18 | Regulated Protein | [42] | |||
Unconventional myosin-Id | Regulated Protein | [9] | |||
Unconventional myosin-X | Regulated Protein | [38] | |||
UPF0505 protein C16orf62 | Regulated Protein | [9] | |||
Vacuolar protein sorting-associated protein 18 homolog | Regulated Protein | [9] | |||
Vesicle transport protein GOT1B | Regulated Protein | [9] | |||
WW domain binding protein 1-like | Regulated Protein | [9] | |||
Zinc finger protein 248 | Regulated Protein | [9] | |||
Zinc finger protein 254 | Regulated Protein | [9] | |||
Zinc finger protein 28 | Regulated Protein | [9] | |||
Zinc finger protein 431 | Regulated Protein | [35] | |||
Zinc finger protein 493 | Regulated Protein | [9] | |||
Zinc finger protein 561 | Regulated Protein | [9] | |||
Zinc finger protein 611 | Regulated Protein | [9] | |||
Zinc finger protein 652 | Regulated Protein | [25] | |||
Zinc finger protein 714 | Regulated Protein | [35] | |||
Zinc finger protein 83 | Regulated Protein | [9] | |||
Zinc finger protein ZIC 3 | Regulated Protein | [25] | |||
Zinc finger transcription factor Trps1 | Regulated Protein | [35] | |||
References | |||||
REF 1 | MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem. 2006 Jul 7;281(27):18277-84. | ||||
REF 2 | MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med. 2010 Dec;58(8):961-7. | ||||
REF 3 | Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol. 2010 Jan 1;184(1):21-5. | ||||
REF 4 | TGF- conditions intestinal T cells to express increased levels of miR-155, associated with down-regulation of IL-2 and itk mRNA. Mucosal Immunol. 2013 Jan;6(1):167-76. | ||||
REF 5 | Epigenetic regulation of thyroid hormone receptor beta in renal cancer. PLoS One. 2014 May 21;9(5):e97624. | ||||
REF 6 | Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis. 2011 Apr;215(2):286-93. | ||||
REF 7 | Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension. 2012 Dec;60(6):1407-14. | ||||
REF 8 | Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. Br J Cancer. 2013 Jul 23;109(2):452-61. | ||||
REF 9 | Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq. RNA. 2010 Aug;16(8):1610-22. | ||||
REF 10 | miR-155 targets Caspase-3 mRNA in activated macrophages. RNA Biol. 2016;13(1):43-58. | ||||
REF 11 | Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7113-8. | ||||
REF 12 | MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 2008 May;18(5):549-57. | ||||
REF 13 | Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res. 2008 Jul 15;68(14):5540-5. | ||||
REF 14 | Widespread changes in protein synthesis induced by microRNAs.Nature. 2008 Sep 4;455(7209):58-63. | ||||
REF 15 | The miR-124-p63 feedback loop modulates colorectal cancer growth. Oncotarget. 2017 Apr 25;8(17):29101-29115. | ||||
REF 16 | Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. FEBS Lett. 2010 Apr 16;584(8):1481-6. | ||||
REF 17 | Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol. 2007 Dec;81(23):12836-45. | ||||
REF 18 | Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene. 2014 Feb 6;33(6):679-89. | ||||
REF 19 | MiR-155 negatively regulates c-Jun expression at the post-transcriptional level in human dermal fibroblasts in vitro: implications in UVA irradiation-induced photoaging. Cell Physiol Biochem. 2012;29(3-4):331-40. | ||||
REF 20 | MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008 Nov;28(22):6773-84. | ||||
REF 21 | The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis. J Allergy Clin Immunol. 2017 Jun;139(6):1946-1956. | ||||
REF 22 | MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN. Oncotarget. 2016 Dec 20;7(51):84508-84519. | ||||
REF 23 | Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells. Oncol Rep. 2014 Sep;32(3):951-6. | ||||
REF 24 | MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16. J Cell Mol Med. 2012 Oct;16(10):2379-86. | ||||
REF 25 | MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol. 2008 Jun;82(11):5295-306. | ||||
REF 26 | Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4536-41. | ||||
REF 27 | Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199. J Immunol. 2009 Oct 15;183(8):5232-43. | ||||
REF 28 | The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem. 2011 Jan 21;286(3):1786-94. | ||||
REF 29 | Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One. 2011 Apr 26;6(4):e19137. | ||||
REF 30 | MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol. 2008 Nov;143(4):570-80. | ||||
REF 31 | Physiological identification of human transcripts translationally regulated by a specific microRNA. Hum Mol Genet. 2005 Dec 15;14(24):3813-21. | ||||
REF 32 | Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6982-7. | ||||
REF 33 | Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function. Am J Cancer Res. 2016 Nov 1;6(11):2561-2574. | ||||
REF 34 | Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J Biol Chem. 2010 Jan 8;285(2):1529-43. | ||||
REF 35 | MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets. PLoS One. 2012;7(7):e40676. | ||||
REF 36 | miR-155 drives telomere fragility in human breast cancer by targeting TRF1. Cancer Res. 2014 Aug 1;74(15):4145-56. | ||||
REF 37 | Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J Virol. 2009 Dec;83(23):12009-17. | ||||
REF 38 | MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J Virol. 2010 Jul;84(13):6318-27. | ||||
REF 39 | MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12885-90. | ||||
REF 40 | Borna disease virus encoded phosphoprotein inhibits host innate immunity by regulating miR-155. Antiviral Res. 2013 Apr;98(1):66-75. | ||||
REF 41 | Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol. 2008 Nov;82(21):10436-43. | ||||
REF 42 | MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem. 2010 Dec 31;285(53):41328-36. | ||||
REF 43 | Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq. RNA. 2010 Aug;16(8):1610-22. | ||||
REF 44 | A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference.Nucleic Acids Res. 2009 Feb;37(3):e24. | ||||
REF 45 | MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets. PLoS One. 2012;7(7):e40676. | ||||
REF 46 | MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol. 2008 Jun;82(11):5295-306. | ||||
REF 47 | MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.J Clin Invest. 2012 Nov;122(11):4190-202. | ||||
REF 48 | MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages.Mol Cell Biol. 2012 Jun;32(12):2239-53. | ||||
REF 49 | MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J. 2014 Jun;28(6):2551-65. | ||||
REF 50 | MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1.J Cell Mol Med. 2011 Jul;15(7):1474-82. | ||||
REF 51 | Quantitative proteomics identify novel miR-155 target proteins.PLoS One. 2011;6(7):e22146. | ||||
REF 52 | Sterile alpha motif and histidine/aspartic acid domain-containing protein 1 (SAMHD1)-facilitated HIV restriction in astrocytes is regulated by miRNA-181a.J Neuroinflammation. 2015 Apr 8;12:66. | ||||
REF 53 | Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6982-7. | ||||
REF 54 | miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood. 2011 Apr 21;117(16):4293-303. | ||||
REF 55 | Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma. Hum Pathol. 2014 Oct;45(10):1995-2005. | ||||
REF 56 | Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3.J Pathol. 2011 Oct;225(2):232-42. | ||||
REF 57 | MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.J Biol Chem. 2010 Jun 4;285(23):17869-79. | ||||
REF 58 | MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol. 2008 Nov;143(4):570-80. | ||||
REF 59 | Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2.Int J Mol Med. 2016 May;37(5):1274-80. | ||||
REF 60 | miR-155 regulates HGAL expression and increases lymphoma cell motility.Blood. 2012 Jan 12;119(2):513-20. | ||||
REF 61 | Widespread changes in protein synthesis induced by microRNAs.Nature. 2008 Sep 4;455(7209):58-63. | ||||
REF 62 | MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med. 2010 Dec;58(8):961-7. | ||||
REF 63 | Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.Oncotarget. 2016 Jan 19;7(3):2391-400. | ||||
REF 64 | MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2735-40. | ||||
REF 65 | The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling.Nat Immunol. 2013 Jun;14(6):593-602. | ||||
REF 66 | Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells.Eur J Immunol. 2010 Jan;40(1):225-31. | ||||
REF 67 | Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol. 2007 Dec;81(23):12836-45. | ||||
REF 68 | MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1.PLoS One. 2013 Dec 23;8(12):e83055. | ||||
REF 69 | Interferon--induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS Lett. 2012 Sep 21;586(19):3255-62. | ||||
REF 70 | miR-155 Regulates Glioma Cells Invasion and Chemosensitivity by p38 Isforms In Vitro. J Cell Biochem. 2015 Jul;116(7):1213-21. | ||||
REF 71 | MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem. 2010 Dec 31;285(53):41328-36. | ||||
REF 72 | Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes.Arch Virol. 2010 Nov;155(11):1823-37. | ||||
REF 73 | A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages.PLoS Pathog. 2012 Sep;8(9):e1002937. | ||||
REF 74 | Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma.Am J Pathol. 2012 Jul;181(1):26-33. | ||||
REF 75 | Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J Virol. 2009 Dec;83(23):12009-17. | ||||
REF 76 | Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.Mol Carcinog. 2014 Sep;53(9):711-21. | ||||
REF 77 | RPTOR, a novel target of miR-155, elicits a fibrotic phenotype of cystic fibrosis lung epithelium by upregulating CTGF.RNA Biol. 2016 Sep;13(9):837-47. | ||||
REF 78 | LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.Blood. 2012 Aug 23;120(8):1678-86. | ||||
REF 79 | microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma.Nucleic Acids Res. 2011 Mar;39(5):1880-93. | ||||
REF 80 | MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN. Oncotarget. 2016 Dec 20;7(51):84508-84519. | ||||
REF 81 | MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer. Am J Transl Res. 2015 Oct 15;7(10):2115-26. | ||||
REF 82 | Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia. 2009 Feb;11(2):167-76. | ||||
REF 83 | Chromosome 21-derived hsa-miR-155-5p regulates mitochondrial biogenesis by targeting Mitochondrial Transcription Factor A (TFAM).Biochim Biophys Acta. 2015 Jul;1852(7):1420-7. | ||||
REF 84 | MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN).J Biol Chem. 2009 Jun 12;284(24):16334-42. | ||||
REF 85 | Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.Cancer. 2012 May 1;118(9):2431-42. | ||||
REF 86 | Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16170-5. | ||||
REF 87 | MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J Virol. 2010 Jul;84(13):6318-27. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.